share_log

WUXI BIO: DATE OF BOARD MEETING

HKEX ·  Feb 11 07:31

Summary by Futu AI

藥明生物技術有限公司宣佈,將於2026年3月24日(星期二)召開董事會會議,主要議程為審議及批准集團截至2025年12月31日止年度的全年業績,並討論相關業績公告的刊發事宜。公司董事會現由執行董事陳智勝博士、Sherry Xuejun Gu博士,非執行董事李革博士(董事長)、曹彥凌先生及繆靜雯女士,以及獨立非執行董事William Robert Keller先生、Kenneth Walton Hitchner III先生、戴國良先生及陳珏博士組成。
藥明生物技術有限公司宣佈,將於2026年3月24日(星期二)召開董事會會議,主要議程為審議及批准集團截至2025年12月31日止年度的全年業績,並討論相關業績公告的刊發事宜。公司董事會現由執行董事陳智勝博士、Sherry Xuejun Gu博士,非執行董事李革博士(董事長)、曹彥凌先生及繆靜雯女士,以及獨立非執行董事William Robert Keller先生、Kenneth Walton Hitchner III先生、戴國良先生及陳珏博士組成。
Wuxi Bio announced that it will convene a board meeting on Tuesday, March 24, 2026. The primary agenda will include the review and approval of the Group's annual financial results for the year ended December 31, 2025, along with discussions regarding the publication of the relevant earnings announcement.The current Board of Directors is composed of Executive Directors Dr. Zhisheng Chen and Dr. Sherry Xuejun Gu, Non-Executive Directors Dr. Ge Li (Chairman), Mr. Yanling Cao, and Ms. Jingwen Miao, as well as Independent Non-Executive Directors Mr. William Robert Keller, Mr. Kenneth Walton Hitchner III, Mr. Guoliang Dai, and Dr. Jue Chen.
Wuxi Bio announced that it will convene a board meeting on Tuesday, March 24, 2026. The primary agenda will include the review and approval of the Group's annual financial results for the year ended December 31, 2025, along with discussions regarding the publication of the relevant earnings announcement.The current Board of Directors is composed of Executive Directors Dr. Zhisheng Chen and Dr. Sherry Xuejun Gu, Non-Executive Directors Dr. Ge Li (Chairman), Mr. Yanling Cao, and Ms. Jingwen Miao, as well as Independent Non-Executive Directors Mr. William Robert Keller, Mr. Kenneth Walton Hitchner III, Mr. Guoliang Dai, and Dr. Jue Chen.

The translation is provided by third-party software.


The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.